Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

United Therapeutics (UTHR) Shares Outstanding (Diluted Average) (2018 - 2025)

United Therapeutics (UTHR) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $47.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 1.24% to $47.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.9 million through Dec 2025, down 1.24% year-over-year, with the annual reading at $47.9 million for FY2025, 1.24% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $47.9 million in Q4 2025 for United Therapeutics, roughly flat from $48.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $49.7 million in Q4 2023 to a low of $46.4 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $48.4 million across 5 years, with a median of $48.5 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 6.77% in 2021 and later decreased 2.41% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $47.3 million in 2021, then rose by 2.54% to $48.5 million in 2022, then increased by 2.47% to $49.7 million in 2023, then decreased by 2.41% to $48.5 million in 2024, then decreased by 1.24% to $47.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for UTHR at $47.9 million in Q4 2025, $48.1 million in Q3 2025, and $48.5 million in Q2 2025.